For pulmonary diseases, inhibition or deletion of sEH reduced cigarette smoke-induced pulmonary inflammation [8], bleomycin-induced pulmonary fibrosis [9], angiotensin II-induced ALI [10]. This evidence concerns the gene EPHX2 and lung disorder.